XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 06, 2022
Jan. 06, 2022
Jan. 02, 2021
Jan. 02, 2017
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2019
Jan. 01, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Stock options outstanding         5,504,861         5,504,861   5,520,861    
Stock options outstanding weighted average exercise price         $ 1.84         $ 1.84   $ 1.84    
Stock options. intrinsic value         $ 0         $ 0        
Options to purchase shares                   50,000        
Stock options exercise price                   $ 1.21        
Stock options, weighted average remaining contractual term                   5 years 7 months 28 days   6 years 3 months 25 days    
Warrant shares, outstanding         6,148,630         6,148,630   6,132,630    
Option exercise price                          
Employees [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Share based compensation expense         $ 49,685         $ 149,055        
Unamortized stock option expense               $ 107,079     $ 107,079      
Non-Employees [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Share based compensation expense               164,994   496,505        
Unamortized stock option expense         1,499,101         $ 1,499,101        
Weighted average period for unamortized stock compensation                   2 years 3 months        
Share-Based Payment Arrangement, Option [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Options to purchase shares                   50,000 583,000      
Stock options exercise price                   $ 1.21 $ 5.60      
Share based compensation expense         214,679     231,649   $ 645,560 $ 1,300,590      
Share-Based Payment Arrangement, Option [Member] | Settlement of Accrued Compensation [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Options to purchase shares 50,000                          
Stock options exercise price $ 1.21                          
Stock options, fair value $ 68,614                          
Stock options, weighted average remaining contractual term 10 years                          
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Share based compensation expense         195,624     230,173   568,198 1,296,162      
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Share based compensation expense         19,055     $ 1,476   77,362 4,428      
Equity Option [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Unamortized stock option expense         $ 1,606,180         $ 1,606,180        
2016 Plan [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Number of additional shares granted     569,826 564,378                    
Number of shares available for grant       1,693,134 6,175,489         6,175,489   5,438,449   737,040
Number of shares for employee benefit                   172,762     564,278  
Common Stock [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Number of conversion of shares of notes and interest           31,983 43,666 176,666 839,724 75,649        
Warrant [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Share based compensation expense         $ 20,433     $ 0   $ 20,433 $ 0      
Warrant shares, outstanding         6,148,630         6,148,630        
Class of warrant or right, outstanding, weighted average exercise price         $ 3.37         $ 3.37        
Class of warrant or right, outstanding, intrinsic value         $ 0         $ 0        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period 16,000                          
Warrants to purchase common stock 16,000 16,000                        
Options expiration period   5 years                        
Option exercise price $ 1.25